Jupiter Neurosciences implements a reverse split to meet Nasdaq’s minimum bid price rule, effective August 6.
Jupiter Neurosciences (NASDAQ: JUNS) approved a 1-for-75 reverse stock split to comply with Nasdaq’s minimum bid price requirement. The move follows regulatory pressure to maintain listing standards.
The split will take effect after market close on August 6, with trading expected to resume under the adjusted structure. Nasdaq rules mandate a minimum $1 bid price for continued listing, a threshold JUNS had failed to meet.
No immediate market reaction was disclosed, but reverse splits often aim to stabilize share prices and avoid delisting risks.